Lipocine Inc

Insider buying spree at Lipocine: John Higuchi and CEO Mahesh Patel purchase shares amid sharp decline, hinting at potential confidence in future catalysts.

Insider buying surge at Lipocine Inc. signals CEO confidence amid a tough market—potential upside for investors in the oral‑delivery space.

Insider buying of Lipocine shares signals confidence amid steep volatility. Discover how Higuchi’s recent purchase may signal undervaluation and future upside.

CEO’s fresh buy at $2.03 shows Lipocine stock may rebound from its 52‑week low, signaling undervaluation and potential upside for investors.

CEO Patel Mahesh V. buys 25,000 Lipocine shares at $2.02, signaling confidence amid steep 72% decline and volatile sentiment—what does this mean for investors?